A Comparative Analysis of Traditional Korean and Chinese Medicine Treatments for Lung Cancer: from a Cancer Treatment Book and Case Reports
Article information
J Korean Med. 2024;45(3):91-102
Publication date (electronic) : 2024 September 1
doi :
https://doi.org/10.13048/jkm.24040
Received 2024 July 9; Revised 2024 July 25; Accepted 2024 August 19.
Abstract
Objectives
Recent trends in traditional Korean medicine (TKM) lung cancer treatment involve the administration of a few ready-made herbal formulas in batches. However, utilizing a TKM pathology-based formulation of herbs can fill in the gaps in holistic treatment that are often missed in a one-size-fits-all approach. The author aimed to analyze treatment trends between a traditional Chinese medicine (TCM) cancer treatment specialty book and a series of Korean lung cancer TKM treatment case reports.
Methods
The frequently used pattern identification types, herbal formulas, and herbs in the lung cancer chapter of a TCM cancer treatment specialty book and case reports of TKM treatment of lung cancer were analyzed in a comparative manner.
Results
Twenty-four pattern identification types for lung cancer were derived from the TCM book, and they were Phlegm-blood stasis, lung heat, and deficiency type. Six types of pattern identification types were derived from the 20 cases reports of TKM treatment, and they were blood stasis due to qi stagnation and deficiency type. Twelve cases were treated with ready-made anti-tumor herbal preparations without performing a pattern identification, accounting for two-thirds of the cases.
Conclusions
The treatment of lung cancer in TCM is characterized by the use of pattern identification to formulate herbal formulas with simultaneous administration of anti-tumor herbs within the same formula. The treatment of lung cancer in TKM is relatively infrequent in its use of pattern identification. In addition, herbal formulas derived through the process of pattern identification and derived for anti-tumor purposes were often administered separately.
Keywords: lung cancer; pattern identification; traditional Korean medicine; traditional Chinese medicine; traditional pathology
Pattern Identification of Lung Cancer Patients
Subtypes of 痰瘀 Type and Lists of Herbs Used for Treatment
Subtypes of 肺熱 Type and Lists of Herbs Used for Treatment
Pattern Identification and List of Herbs of Lung Cancer Patients from Case Reports in Korea
List of Herbs Contents in Ready-made Herbal Formula Prescribed without Pattern Identification Process
References
1. Wang X. Y., Gan Z. W.. 2017. Classic of Difficult Issues and Variorum of the Classic of Difficult Issues Beijing/China: Academy press. p. 48.
2. Kim K., Moon J.. 2014. A translated Huangdi’s Internal Classic Miraculous Pivot Seoul/Republic of Korea: Bubin publishers. p. 45.
3. Wang X. Y., Gan Z. W.. 2017. Classic of Difficult Issues and Variorum of the Classic of Difficult Issues Beijing/China: Academy press. p. 243.
4. Li Z.. 2002. Chapter 4. Primary lung cancer. Clinical experience series of famous traditional Chinese medical doctors in specilized diseases: Oncology Beijing/China: People’s Medical Publishing House. p. 23–60.
5. Health Insurance Review & Assessment Service. Traditional Korean Medicine Classification System Statistics [internet] Health Insurance Review & Assessment Service; 2022. [cited 2024 Jan 24]; Available from: https://www.hira.or.kr/bbsDummy.do?pgmid=HIRAA020045010000&brdScnBltNo=4&brdBltNo=2394&pageIndex=1&pageIndex2=1#none.
6. Cornfield J., Haenszel W., Hammond E. C., Lilienfeld A. M., Shimkin M. B., Wynder E. L.. 1959;Smoking and Lung Cancer: Recent Evidence and a Discussion of Some Questions. Journal of the National Cancer Institute 22(1):173–203.
http://doi.org/10.1093/jnci/22.1.173.
7. Huang F., Pan B., Wu J., Chen E., Chen L.. 2017;Relationship between exposure to PM2.5 and lung cancer incidence and mortalit y: A meta-analysis. Oncotarget 8(26):43322–43331.
http://doi.org/10.18632/oncotarget.17313.
8. Won J., Hwang C., Kim K., Song B., Kim C., Sung G., et al. 2008. Refined Dongeuibogam Seoul/Republic of Korea: HANMI Medical Publishing. p. 681–682.
9. Jung H., Kim J.. 2015;The role of Korean medicine for treatment and management for lung cancer. Journal of Korean Traditional Oncology 20(1):45–54.
https://doi.org/10.15432/JKTO.2015.20.1.045.
10. Salm S., Rutz J., Akker M. V. D., Blaheta R. A., Bachmeier B. E.. 2023;Current state of research on the clinical benefits of herbal medicines for non-life-threatening ailments. Frontiers in pharmacology 14:1234701.
11. Cho H.. 2023;Development and application of Korean Medicine Education Model introducing Syndrome Differentiation-based Clinical Performance Examination. [report]
12. Lee C.. 2017. Some clinical reflections on the treatment of cancer by traditional Chinese medicine. In : Huang J., Wang S., eds. Cancer expert forum series 1 Beijing/China: China Medical Science Press. p. 79–87.
13. Chang S.. 2016. Chinese herbal medicine including historical aspects Herbal Medicines. New Horizons: p. 1–7.
14. Shin S.. 2001. Reading Medical Articles Properly: Understanding Evidence-Based Medicine Seoul/Republic of Korea: Body and Mind. p. 192–204.
15. Gong C. Z., Ma S. B.. 2009. Series of books on strange prescriptions for diseases difficult to treat: Yunnanbaiyao Beijing/China: China Medical Science Press. p. 5.
16. Yang J., Zhang Y.. 2021;Research progress on anti-tumor effect of extracted parts and active components of Ranunculus ternatus. Drug Evaluation Research 44(2):446–451.
https://doi.org/10.7501/j.issn.1674-6376.2021.02.030. (in Chinese).
17. Zhao H., Wu H. Y., Fan X. R., Xu S. Q., Fan H. F.. 2023;Review on the mechanism of the antitumor action of Solanum lyratum Thunberg alkaloid. Global Traditional Chinese Medicine 16(2):360–364.
(in Chinese).
18. Dai Y. Y., Zhu J. F., Liu X.. 2023;Research Progress on Pharmacological Action and Clinical Application of Shemei. Western Journal of Traditional Chinese Medicine 36(3):155–7.
https://doi.org/10.12174/j.issn.2096-9600.2023.03.32. (in Chinese).
19. Liu Y., Qian R. K., Qan R. H.. 2018;Research progress on anti-tumor effects of Shi Jian Chuan and its extracts. Modern Journal of Integrated Traditional Chinese Western Medicine 27(30):3417–3420.
https://doi.org/10.3969/j.issn.1008-8849.2018.30.034. (in Chinese).
20. Chen H., He L. J., Lin L. F.. 2014;Research progress on the anti-tumor mechanism of Fagopyrum dibotrys. Strait Pharmaceutical Journal 26(4):41–42.
(in Chinese).
21. Shi Y., Chen Z., Liang Y., Qin R., Hou B., Wu S.. 2023;Research Advances on Chemical Constituents and Pharmacology of Artemisia rupestris L. China Journal of Pharmaceutical Economics 18(3):109–113.
https://doi.org/10.12010/j.issn.1673-5846.2023.03.025. (in Chinese).
22. Qian F. F., Que Z. J., Tian J. H.. 2018;Research progress on the anti-tumor mechanism of Chonglou saponin. Oncology Progress 16(14):1709–1712.
https://doi.org/10.11877/j.issn.1672-1535.2018.16.14.06. (in Chinese).
23. Wang S., Ma S., Yan Y., Cheng Z., Zhang Y., Liu T.. 2017;Study on pharmacognosy identification and screening of anti-tumor part from Cyeas revotuta. Lishizhen Medicine and Materia Medica Research 28(8):1910–1912.
https://doi.org/10.3969/j.issn.1008-0805.2017.08.040. (in Chinese).
24. Hu Q., Zhu D., Tan X., Li Y., Zhu K.. 2019;Antitumor effect and mechanism of Clerodendron Bungei extract on H22 tumorbearing mice. The Chinese Journal of Clinical Pharmacology 35(14):1459–1462.
https://doi.org/10.13699/j.cnki.1001-6821.2019.14.013. (in Chinese).
25. Wei Q., Qiu Z., Xu F., Li Q., Yin H.. 2015;Chemical Components from Leaves of Fatsia japonica and Their Antitumor Activities in vitro. Journal of Chinese Medicinal Materials 38(4):745–750.
https://doi.org/10.13863/j.issn1001-4454.2015.04.023. (in Chinese).
26. Liu J., Qi D. Y., Zhao Z. H., Li G., Han Y. G.. 2022;Research of the Mechanism of Akebia Trifoliata Koidz Aqueous Extract on Glial Cells EMT. Hebei Medicine 28(2):201–207.
https://doi.org/10.3969/j.issn.1006-6233.2022.02.05. (in Chinese).
27. Park S., Kim D., Han C., Park S., Lee I., Choi J.. 2011;Integrated Medicine Therapy for an End-stage Lung Cancer Patient with Brain Metastasis. Journal of Korean Traditional Oncology 16(2):43–51.
https://doi.org/10.15432/JKTO.2011.16.2.043.
28. Yeom J., Ahn S., Park S., Oh S.. 2022;Korean Medicine-based Integrative Oncology Therapies on adverse effects of Chemotherapy in Non-Small Cell Lung Cancer: 2 Cases. Journal of Korean Traditional Oncology 27(1):57–66.
https://doi.org/10.15432/JKTO.2022.27.1.057.
29. Cho Y., Yang J., Joo H., Park S., Park J., Yoo H.. 2023;A Case Report on the Improvement of Cancer Pain in a Patient with Metastatic Non-Small Cell Lung Cancer Through Herbal Medicine-based Integrative Cancer Treatment with Chemotherapy. The Journal of Internal Korean Medicine 44(3):594–601.
http://dx.doi.org/10.22246/jikm.2023.44.3.594.
30. Choi Y., Kim J., Bae K., Cho C., Yoo H. S.. 2017;A Case of Non-Small Cell Lung Carcinoma Patient Who Improved Skin Rash Due to Olmutinib by Administration of Nobongsangki-Jeong. Journal of Korean Traditional Oncology 22(1):13–22.
https://doi.org/10.15432/JKTO.2017.22.1.013.
31. Kim J., Bae K., Park S., Cho C., Yoo H.. 2017;A Case of Patient with Recurring Non-Small Cell Lung Carcinoma Treated with Samchilchoongcho-Jung in Conjunction with Afatinib. The Journal of Internal Korean Medicine 38(1):72–80.
http://dx.doi.org/10.22246/jikm.2017.38.1.72.
32. Bang S., Yun Y., Choi J., Han C., Kim S., Park S., Lee I.. 2021;Case Report on Complete Response and 5 year Survival of Non-Small Cell Lung Cancer IIIB Patient Treated with Integrative Medicine. Journal of Korean Medicine 42(1):119–128.
http://dx.doi.org/10.13048/jkm.21009.
33. Lee J., Park H., Chae J., Kim K., Jung H., Lee S., Cheon S.. 2011;Case Report: Long-term Survival and Good-Quality of Life in Metastatic Non-small Cell Lung Cancer Patients Treated with Allergen-removed Rhus verniciflua Stokes (aRVS) as Sequential and Concurrent Treatment with Chemotherapy. The Journal of Internal Korean Medicine 32(1):129–135.
34. Kang J., Kim J., Son C., Cho J.. 2015;Long-Term Survival of Patients with Lung Cancer Treated by Traditional Korean Medicine Combined with Western Treatment: Report of Two Cases. The Journal of Internal Korean Medicine 36(1):58–68.
35. Choi J., Yoo H., Son C., Cho C.. 2005;Regression of small cell lung carcinoma by herbal medicine a case with an 8-year follow-up. Journal of Korean Traditional Oncology 10(1):87–91.
36. Ha S. J., Song S. Y., Park S., Jeon H., Lee Y., Cho C., Yoo H.. 2018;A case of patient with non-small cell lung carcinoma treated with samchilchoongcho-jung in conjunction with crizotinib. Journal of Korean Traditional Oncology 23(1):23–32.
https://doi.org/10.15432/JKTO.2018.23.1.023.
37. Hong M., Lee J. H., Park H. L., Lee H. Y., Cho M. K., Han C. W., Choi J. Y.. 2014;Acute analgesic effect of electroacupuncture on a cancer pain in a small cell lung cancer patient: a case report. Journal of Physiology & Pathology in Korean Medicine 28(6):689–694.
http://dx.doi.org/10.17208/kjopp.2014.12.28.6.689.
38. Seo H. G., Jin Y. J., Song M. H., Kim I. T., Park J. H., Jung J. S., Shin K. S.. 2018;A Case of End-stage non-small cell Lung Cancer Patient with Brain Metastasis Treated with Pembrolizumab with Integrative Medicine Therapy. Journal of Korean Traditional Oncology 23(2):11–25.
https://doi.org/10.15432/JKTO.2018.23.2.011.
39. Zheng H., Yoon J., Lee Y., Cho C., Oh D., Yoo H.. 2011;Case series of advanced non-small cell lung cancer patients treated with Hang-Am Plus. The Journal of Internal Korean Medicine 32(1):113–120.
40. Lee G., Park C., Cho J., Son C., Lee N.. 2020;The Effect of Chunggan Plus Extract in Improving Liver Function: A Retrospective Case Series of Eight Patients. The Journal of Internal Korean Medicine 41(3):542–551.
41. Chang S.. 2015;Letter to Editor: Gamchosasim -tang, Sawi-tang and Giotrif Combination Therapy for Metastatic Non-Small-Cell Lung Adenocarcinoma; A Regression Case. Journal of Korean Traditional Oncology 20(2):1–4.
42. Yu S., Eo W., Yoon S.. 2008;One case report of non-small cell lung cancer patients treated with allergen removed Rhus Verniciflua Stokes (aRVS). Journal of Korean Traditional Oncology 13(1):63–69.
43. Shim S., Seo H., Choi J., Bae G., Seo H., Kim S., Choi J.. 2018;Traditional Korean Medicine for Skin Toxic Side Effects from Afatinib in a Non-Small Cell Lung Cancer Patient: A Case Report. The Journal of Internal Korean Medicine 39(5):973–983.
http://dx.doi.org/10.22246/jikm.2018.39.5.97.
44. Yang J., Jang H., Song S., Park J., Park S., Yoo H.. 2022;A Case Report on the Therapeutic Effect of Integrated Cancer Therapy for Glioblastoma Multiforme. The Journal of Internal Korean Medicine 43(2):320–325.
https://doi.org/10.22246/jikm.2022.43.2.320.